Tien Liang Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 12, 2019 at 11:24 pm IST
Share
Tien Liang BioTech Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 94.724 million compared to TWD 121.039 million a year ago. Operating loss was TWD 18.681 million compared to TWD 21.535 million a year ago. Net loss was TWD 25.080 million compared to TWD 36.019 million a year ago. Basic loss per share was TWD 0.55 compared to TWD 0.79 a year ago. For the nine months, sales was TWD 305.089 million compared to TWD 386.676 million a year ago. Operating loss was TWD 55.601 million compared to TWD 44.744 million a year ago. Net loss was TWD 59.400 million compared to TWD 63.601 million a year ago. Basic loss per share was TWD 1.3 compared to TWD 1.39 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.
TIEN LIANG BIOTECH CO., LTD. 
